{"transactions":[{"id":4635941,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:05:06.000Z","date":"2026-10-02","kind":"sale","planned":false,"acquired":false,"shares":1864,"price":12.43,"value":23169.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2026, and does not represent a volitional trade by the Reporting Person."}],"balance_after":65022,"source":{"system":"sec-edgar","filing":"0001193125-26-415541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000119312526415541/ownership.xml","form_type":"4"}},{"id":715719,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-06T21:02:06.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":2641,"price":16.78,"value":44315.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2026, and does not represent a volitional trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.78 to $17.12, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2026 at each separate price."}],"balance_after":66886,"source":{"system":"sec-edgar","filing":"0002019493-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000201949326000002/ownership.xml","form_type":"4"}},{"id":868696,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:15:37.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":69527,"source":{"system":"sec-edgar","filing":"0001193125-26-088236","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000119312526088236/ownership.xml","form_type":"4"}},{"id":944841,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:01:51.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":2989,"price":9.21,"value":27528.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person."}],"balance_after":52277,"source":{"system":"sec-edgar","filing":"0001193125-26-006264","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000119312526006264/ownership.xml","form_type":"4"}},{"id":1024945,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-10-03T21:13:00.000Z","date":"2025-10-01","kind":"sale","planned":false,"acquired":false,"shares":1871,"price":17.38,"value":32517.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":55266,"source":{"system":"sec-edgar","filing":"0001193125-25-230420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000119312525230420/ownership.xml","form_type":"4"}},{"id":1092828,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-07-03T20:07:21.000Z","date":"2025-07-02","kind":"sale","planned":false,"acquired":false,"shares":2503,"price":9.95,"value":24904.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":57137,"source":{"system":"sec-edgar","filing":"0000950170-25-093844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000095017025093844/ownership.xml","form_type":"4"}},{"id":1229973,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:28:45.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":59640,"source":{"system":"sec-edgar","filing":"0000950170-25-032141","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000095017025032141/ownership.xml","form_type":"4"}},{"id":1308441,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-01-07T22:23:13.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":1372,"price":12.18,"value":16710.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":45640,"source":{"system":"sec-edgar","filing":"0000950170-25-003032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000095017025003032/ownership.xml","form_type":"4"}},{"id":1390917,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-10-04T21:29:43.000Z","date":"2024-10-02","kind":"sale","planned":false,"acquired":false,"shares":2012,"price":19.01,"value":38248.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2024, and does not represent a volitional trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.01, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 2, 2024 at each separate price."}],"balance_after":47012,"source":{"system":"sec-edgar","filing":"0000950170-24-112980","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000095017024112980/ownership.xml","form_type":"4"}},{"id":1460580,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":32222,"kind":"person","name":"Dube Michael P","position":1,"cik":"0002019493","reported_name":"Dube Michael P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, PAO and Interim PFO"}}],"security":"Common Stock","published_at":"2024-07-03T17:15:03.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":17801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":49024,"source":{"system":"sec-edgar","filing":"0000950170-24-081258","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019493/000095017024081258/ownership.xml","form_type":"4"}}]}